Lei Gong

4.3k citations
119 papers · 2.8k indexed · h-index 26
Topics
Esophageal Cancer Research and Treatment (30 papers)Gastric Cancer Management and Outcomes (21 papers)Lung Cancer Treatments and Mutations (19 papers)
Partner nations
ChinaUnited StatesMexico

In The Last Decade

Lei Gong

111 papers receiving 2.8k citations

Peers

Lei Gong
Comparison fields: 5 of 146
  • Molecular Biology 965
  • Oncology 929
  • Pulmonary and Respiratory Medicine 682
  • Immunology 469
  • Surgery 458
Replace Hans Wolf with:
Hans Wolf Denmark
Jie Chen China
Till Braunschweig Germany
Petra Zürbig Germany
Joanna Polańska Poland
Julie Klein France
Sanjun Cai China
Hsuan‐Yu Chen Taiwan
Cheng‐Ping Yu Taiwan
Bo Feng China
Lei Gong relative to Hans Wolf Denmark Hans Wolf's profile →
Citations per field
00.5×8.9×
Hans Wolf · 1×
Citations per year

Countries citing papers authored by Lei Gong

Since Specialization
Citations

This map shows the geographic impact of Lei Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Gong more than expected).

Fields of papers citing papers by Lei Gong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Gong. The network helps show where Lei Gong may publish in the future.

Co-authorship network of co-authors of Lei Gong

This figure shows the co-authorship network connecting the top 25 collaborators of Lei Gong. A scholar is included among the top collaborators of Lei Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Gong. Lei Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 3
5 13
6 3
7 11
8 6
9 60
10 1
11 0
12 45
13 3
14 1
15 169
16 51
17 148
18 1
19 18
20 342

About Lei Gong

Lei Gong is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 119 papers that have together received 2.8k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (30 papers), Gastric Cancer Management and Outcomes (21 papers) and Lung Cancer Treatments and Mutations (19 papers). The work is most often cited by research in Oncology (929 citations), Spectroscopy (392 citations) and Immunology (469 citations). Lei Gong has collaborated with scholars based in China, United States and Mexico. Frequent co-authors include Suhail Nasim, Antonia Vlahou, Seyed Javad Moghaddam, Amber M. Cumpian, Mauricio S. Caetano, Seyedeh Golsar Mirabolfathinejad, George L. Wright, Seon Hee Chang, Paul F. Schellhammer and Filippos I. Kondylis. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026